OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
25 hedge funds and large institutions have $13.3M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
25
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.02M | |
| 2 | +$504K | |
| 3 | +$363K | |
| 4 |
ACA
Apis Capital Advisors
New York
|
+$256K |
| 5 |
Renaissance Technologies
New York
|
+$229K |
Top Sellers
| 1 | -$292K | |
| 2 | -$283K | |
| 3 | -$191K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$21K |
| 5 |
BlackRock
New York
|
-$3.37K |